--- title: "GLARUNTECH: Vice President Xu Yun and Zheng Yi resigned due to job changes" type: "News" locale: "en" url: "https://longbridge.com/en/news/232700522.md" description: "On March 21st, GLARUNTECH announced that the company's board of directors recently received resignation letters from Vice General Managers Xu Yun and Zheng Yi. The two resigned from their positions due to job changes and will no longer hold any positions in the company or its subsidiaries after their resignation. The resignation letters will take effect from the date they are delivered to the company's board of directors" datetime: "2025-03-21T07:57:44.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/232700522.md) - [en](https://longbridge.com/en/news/232700522.md) - [zh-HK](https://longbridge.com/zh-HK/news/232700522.md) generator: "portal-rs" --- # GLARUNTECH: Vice President Xu Yun and Zheng Yi resigned due to job changes On March 21, GLARUNTECH announced that the company's board of directors recently received resignation letters from Deputy General Managers Xu Yun and Zheng Yi. The two resigned from their positions due to job changes and will no longer hold any positions in the company or its subsidiaries after their resignation. The resignation letters will take effect from the date they are delivered to the company's board of directors ### Related Stocks - [600562.CN](https://longbridge.com/en/quote/600562.CN.md) ## Related News & Research - [Webrock Ventures board member Christina Källenfors resigns with immediate effect](https://longbridge.com/en/news/297613093.md) - [REG - Windar Photonics PLC - Holding(s) in Company](https://longbridge.com/en/news/297772032.md) - [Canada's Zoomd Technologies Q2 revenue falls sharply on operating model changes](https://longbridge.com/en/news/297510644.md) - [Eneva swaps coal asset for full control of LNG-linked infrastructure in Pecém](https://longbridge.com/en/news/297785249.md) - [Knight Therapeutics wins Colombia approval for Tavalisse in chronic ITP](https://longbridge.com/en/news/297703037.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**